Skip to main content

Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones.

Qiu J, Kulkarni S, Chandrasekhar R, Rees M, Hyde K, Wilding G, Tan D, Khoury T

Publication: Am J Clin Pathol (2010) • Vol 134 • Page 813-9PMID: 20959666View on PubMed

Purpose

This paper examined effects of cold ischemia on estrogen receptor (ER) and progesterone receptor (PR) immunohistochemical staining (quantified by Q-score) that was assessed using three different commercially available antibodies for each receptor.

Conclusion

Cold ischemia resulted in declining Q-scores for all ER and PR antibodies evaluated, with the first declines for both ER and PR were observed after 1 h, although statistical significance was not assessed. While differences between antibodies with regard to the onset of decline in response to cold ischemia were observable, statistically significant differences in Q-scores between antibodies for a specific time point were limited to ER antibodies ID5 and SP1 after 8 h (P=0.03).

Studies (1)

Purpose

This study examined effects of cold ischemia on estrogen receptor (ER) and progesterone receptor (PR) immunohistochemical staining in breast cancer specimens that were surgically resected from 10 patients.  Breast invasive ductal carcinoma specimens were procured via lumpectomy from 10 patients, processed immediately and fixed as soon as possible (within 2-5 min) or placed in 0.9% NaCl and stored for varying durations (10 min-8 h) at room temperature or at 4°C overnight.  Specimens were fixed in 10% neutral buffered formalin for 12-32 h and were uniformly processed. FFPE specimens were then assembled into tissue microarrays using 0.6 mm cores.  The extent and intensity of immunohistochemical staining was quantified by Q-score. Q-scores were obtained for each receptor using three different commercially available antibodies in formalin-fixed, paraffin-embedded breast tissue specimens subjected to cold ischemia times that ranged between 0 min and overnight incubation at 4°C.  Statistical analysis was limited to comparisons drawn between the different antibodies for a given cold ischemia time point.

Summary of Findings

While cold ischemia resulted in declining Q-scores for all ER and PR antibodies evaluated, antibody-specific differences were observed. The first declines in Q-score occurred after 1 h of cold ischemia for ER when the SP1 antibody was used, and for PR when PgR636 or 16 antibodies were used.  Declines in Q-score for the remaining antibodies were observed after 4 h for ER when ID5 of 6F11 antibodies were used and for PR when the 1E2 antibody was used. Statistically significant differences between antibodies for a specific timepoint were limited to ER antibodies ID5 and SP1 after 8 h (P=0.03).

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinTissue microarray
    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionCold ischemia time
    0 min
    1 h
    10 min
    2 h
    30 min
    4 h
    8 h
    overnight at 4 degrees C
    Immunohistochemistry SpecificType of antibody
    16
    1D5
    1E
    6F11
    PgR636
    SP1